HCW Biologics Inc. (HCWB)
NASDAQ: HCWB · Real-Time Price · USD
0.3494
+0.0098 (2.89%)
At close: May 13, 2026, 4:00 PM EDT
0.3607
+0.0113 (3.23%)
After-hours: May 13, 2026, 7:24 PM EDT

HCW Biologics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
2320446983
Market Cap Growth
-71.70%-83.97%-55.17%-35.50%-17.22%-
Enterprise Value
7.218.0428.8847.0243.0446.27
Last Close Price
0.350.9717.8449.2076.5992.80
PE Ratio
--0.09-0.58-1.76-4.56-3.36
PS Ratio
43.3958.707.7415.5910.22-
PB Ratio
0.411.15-2.933.291.841.62
P/TBV Ratio
0.270.74-2.563.281.830.85
P/FCF Ratio
--0.24-1.37-1.54-3.32-7.53
P/OCF Ratio
--0.24-1.40-1.97-6.61-7.56
EV/Sales Ratio
132.94148.2511.2516.556.40-
EV/EBITDA Ratio
--0.66-1.02-1.91-3.00-3.61
EV/EBIT Ratio
--0.61-0.98-1.83-2.85-3.46
EV/FCF Ratio
--0.60-1.99-1.64-2.08-4.20
Debt / Equity Ratio
2.462.46-2.020.470.170
Debt / EBITDA Ratio
-0.56-0.56-0.48-0.26-0.45-
Debt / FCF Ratio
-0.51-0.51-0.94-0.22-0.31-
Net Debt / Equity Ratio
1.761.76-1.330.20-0.68-0.72
Net Debt / EBITDA Ratio
-0.40-0.40-0.32-0.111.792.86
Net Debt / FCF Ratio
-0.36-0.36-0.62-0.091.243.33
Asset Turnover
0.000.000.090.080.130
Quick Ratio
0.090.090.180.5910.9915.87
Current Ratio
0.110.110.190.7311.5217.44
Return on Equity (ROE)
397.45%397.45%-897.37%-98.23%-33.63%-39.22%
Return on Assets (ROA)
-48.15%-48.08%-100.28%-68.29%-30.06%-38.80%
Return on Invested Capital (ROIC)
-249.65%-249.25%-319.85%-183.95%-114.80%-130.93%
Return on Capital Employed (ROCE)
-648.65%-647.60%-289.16%-80.85%-31.73%-40.76%
Earnings Yield
-947.71%-1095.20%-173.54%-56.91%-21.93%-29.74%
FCF Yield
-569.15%-420.67%-72.94%-64.81%-30.08%-13.28%
Buyback Yield / Dilution
-116.30%-116.30%-7.97%-0.30%-90.84%-296.07%
Total Shareholder Return
-116.30%-116.30%-7.97%-0.30%-90.84%-296.07%
Updated Mar 31, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q